"We are excited to welcome Ferring Pharmaceuticals and the Astellas/Pfizer Alliance as our National Presenting Sponsors for the 2025 Walks to End Bladder Cancer," said Meri-Margaret Deoudes, CEO of ...
(Reuters) -Metsera shareholders on Thursday approved Pfizer's takeover offer worth up to $10 billion, allowing the U.S.
Pfizer has sold a significant portion of its stake in German drugmaker BioNTech SE, a more than five years after the two ...
Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both ...
The GLP-1 agonist at the center of Pfizer’s upfront $4.9 billion buyout of Metsera last week has been tied to 14.1% weight loss at 28 weeks as well as “potentially class-leading tolerability,” ...
Pharmaceutical giant Pfizer has finally acquired development-stage obesity drugmaker Metsera Inc., in an intense bidding war against the Danish drugmaker Novo Nordisk for over $10 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results